About Conference
Parkinson’s congress-2018 invites all the participants from all over the world to attend the parkinsons congress-2018 conference entitled “Global Experts Meeting on Parkinson’s & Movement Disorders” during May 17-18, 2018 Singapore. This gathering is predominantly will focus the most recent and energizing developments in each range of Parkinson’s research, and it will offer an exceptional opportunity for specialists from all over the world to meet, network, and distinguish with different scientific interactions.
Parkinson’s disease is a dynamic neurological disorder that influences how the individual moves, including how they talk and compose. This disease is caused by low dopamine levels. Various useful treatments, utilizing therapies (physiotherapy), surgery and medications have recognized neurological disorders and changes in the patient group. People with Parkinson’s disease also experience stiffness and they find abnormality in carrying out the movements as rapidly as before- this is known as bradykinesia.
The Parkinson’s disease market in US is expected to grow at a rate of 5.3% from sales of of $1.1 billion in 2012 to $1.3 billion in 2022. Approximately 1 million adults in Asia are suffering from Parkinson’s disease, from where 60,000 were diagnosed annually. An estimated of 30%-50% of PD patients mainly suffering from depression. United States is in the fourth position in considering the death of people due to Parkinson’s disease. African Americans have the highest death rate of 66.4% followed by whites of 64.6%, Hispanic with 55.4% and Asians with 50.8%. Parkinson’s disease strikes 50% more men than women. The economic burden of Parkinson’s disease on patients and their families in the Asia is about $9.4 billion.
Why to attend:
It is our great pleasure to welcome you to the “Global Experts Meeting on Parkinson’s & Movement Disorders” during May 17-18, 2018 Singapore.
The Conference will encourage new discoveries and research by providing a platform for reporting of unique and unusual cases which enhance understanding of disease process, its diagnosis, management and clinic-pathologic correlations. It will provide a podium for wide-ranging aspects of psychological, neurological, molecular, genetic and behavioral pathways underlying addiction, and will focus on novel therapies providing quality care for people with unhealthy alcohol, tobacco, or other drug use and addictive behaviors across a spectrum of clinical settings. It will comprise of opening Keynote lectures by the renowned researcher and noble members working in the field of Neourology disorders research and treatment followed by the special workshop and symposium sessions by eminent scholars and therapeutic members for all the three days of the conference.
Target audience:
Neurologists, Psychiatrists, Psychologists, Neurosurgeon, Head of the department, Director, Industries, Delegates, Clinical, Community members, Professors, Researchers, Students, Scientists, Nurses.
- Neurologists and Directors
- Physicians
- Neuroscientists
- Specialists
- Researchers
- Professors
- Industrial Experts
- Neurosurgeons
- Psychiatrist
- Nutritional Scientists
- Lecturers and Students from Academia in the study of Parkinson disease
- Students from Academia in the research of Neurology and Neuroscience
- Therapists
Conference Highlights
- Parkinson’s Disorders
- Epidemiology of Parkinson’s disease
- Neuromuscular Disorders
- Alzheimers Disease and Dementia
- Anxiety and Depression
- Neuropsychiatric Disorders
- Diagnosis for Parkinson’s Disease
- Managing life with Parkinson’s Disease
- Neuroimaging
- Advanced therapies in Parkinson’s Disease
- Movement Disorders
- Movement Disorders risk factors
Special Issues
- All accepted abstracts will be published in respective Omics International Journals.
- Abstracts will be provided with Digital Object Identifier by Cross Ref.
See more at: http://parkinsonscongress.neurologyconference.com/
No comments:
Post a Comment